Papers matching “vaccine candidate evaluation” 37
Not finding it? Sign in to also search OpenAlex live.
-
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults2020 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Immunology Research Open access
Isabel Leroux‐Roels, Geert G Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor P. Cahill, Richard de Rooij, +3 more
8citations -
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery2020 Journal of Pharmaceutical Sciences article Medicine Viral gastroenteritis research and epidemiology Open access
Prashant Kumar, Swathi R. Pullagurla, Ashaben Patel, Ozan S. Kumru, Ahd Hamidi, Femke Hoeksema, +4 more
14citations -
Abstract 4160: Promoting immunogenicity of synthetic long peptide vaccines based on in vivo IgG complex formation: Preclinical evaluation and clinical entry of the TET platform2022 Cancer Research conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses
Erika A.K. Fletcher, Iliana Kyriaki Kerzeli, Robert A. Cordfunke, Aikaterini Nasi, Gunilla Törnqvist, Rob R.P.M. Valentijn, +18 more
1citations -
Synthetic Oligomers Mimicking Capsular Polysaccharide Diheteroglycan are Potential Vaccine Candidates against Encapsulated Enterococcal Infections2020 ACS Infectious Diseases article Chemistry Carbohydrate Chemistry and Synthesis Open access cited by 3 patents
Diana Laverde, Felipe Romero‐Saavedra, Dmitry A. Argunov, Jacopo Enotarpi, Vadim B. Krylov, Ermioni Kalfopoulou, +7 more
28citations -
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial
Etienne Karita, Julien M. Nyombayire, Rosine Ingabire, Amelia Mazzei, Tyronza Sharkey, Jeannine Mukamuyango, +12 more
19citations -
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial2024 The Lancet Infectious Diseases article Immunology and Microbiology HIV Research and Treatment Open access
Glenda Gray, Kathryn Therese Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural, +58 more
46citations -
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI2024 npj Vaccines article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access
Carlos A. Fierro, Michal Sarnecki, Bart Spiessens, Oscar T. Go, Tracey Day, Todd A. Davies, +4 more
19citations -
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 21 patents
Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, Mark J. G. Bakkers, Gijs Hardenberg, Frank Wegmann, +18 more
45citations -
Pre-clinical studies of Schistosoma mansoni vaccines: a scoping review2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Parasites and Host Interactions Open access
Emma L. Houlder, Lucas Ferreira da Silva, Angela van Diepen, Murilo Sena Amaral, Robert Alan Wilson, Cornelis Hendrik Hokke, +2 more
0citations -
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age2022 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Immunology Research Open access
Anna Lisa Ong‐Lim, Georgi Shukarev, Mitzi Trinidad‐Aseron, Delia Caparas-Yu, Astrid E. Greijer, Michel Duchêne, +7 more
4citations -
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months2022 The Journal of Infectious Diseases article Medicine Respiratory viral infections research Open access
Arabella S. V. Stuart, Miia Virta, Kristi L. Williams, Ilkka Seppä, Robyn Hartvickson, Melanie Greenland, +9 more
41citations -
Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review2025 PLoS neglected tropical diseases article Immunology and Microbiology Parasites and Host Interactions Open access
Emma L. Houlder, Lucas Ferreira da Silva, Angela van Diepen, Murilo Sena Amaral, Robert Alan Wilson, Cornelis Hendrik Hokke, +2 more
10citations -
High-throughput epitope screening of the Human Cytomegalovirus immediate early protein 2 identifies promising antigenic T cell targets2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cytomegalovirus and herpesvirus research Open access
Eleni Panagioti, Marij J.P. Welters, Ramon Arens, Sjoerd H. van der Burg
0citations -
Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge2023 Journal of Clinical Investigation article Immunology and Microbiology Bacterial Infections and Vaccines Open access
Annieck M. Diks, Hans de Graaf, Cristina Teodósio, Rick J. Groenland, Bas de Mooij, Muktar Ibrahim, +4 more
15citations -
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months2024 Open Forum Infectious Diseases article Medicine Respiratory viral infections research Open access
Joanne Marie Langley, Terry M. Nolan, Mika Rämet, Peter Richmond, Nelson Augusto Rosário Filho, Wouter Haazen, +10 more
7citations